Thank you for your patience as we work to resolve bugs and issues on the new Register. To see if your issue has already been reported, please view the list of known issues.
This item is authorised by the following title:
For a transitional provision relating to the repeal of this instrument, see section 38 of the National Health (Highly Specialised Drugs Program) Special Arrangement 2021 (PB 27 of 2021).
For a transitional provision relating to the repeal of this instrument, see section 38 of the National Health (Highly Specialised Drugs Program) Special Arrangement 2021 (PB 27 of 2021).